We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,417

Managed Care Lawsuit Watch - February 2017 - Deborah Heart & Lung Center v. Virtua Health, Inc. 833 F.3d 399 (3d Cir. 2016)
  • Crowell & Moring LLP
  • USA
  • February 2 2017

The U.S. Court of Appeals for the Third Circuit affirmed dismissal of a Sherman Act Section 1 antitrust claim brought by New Jersey Hospital Deborah


Global trends in merger control enforcement - February 2017
  • Allen & Overy LLP
  • European Union, Global, United Kingdom, USA
  • February 2 2017

Building on the trends of previous years, companies continued to show a willingness to engage in strategic deals to bring about further consolidation


The French Competition Authority Speaks for the Hard of Hearing
  • Bryan Cave LLP
  • USA, France
  • January 24 2017

Suspecting the high price of hearing aid devices to be the cause of a low rate of ownership in France, the French Competition Authority (the "FCA"


FTC settles abusive acquisition of pharma licensing rights
  • Bristows LLP
  • United Kingdom, USA
  • January 23 2017

On 18 January, the FTC announced that Mallinckrodt ARD Inc. (formerly Questcor Pharmaceuticals, Inc.) and its parent company have agreed to pay $100


Part 2 of 3: The Telemedicine Debate in Texas: Teladoc Sues in Federal Court
  • Kane Russell Coleman & Logan PC
  • USA
  • January 16 2017

The rule issued by the Texas Medical Board requiring physicians to conduct a face-to-face or in-person visit with a patient in order to establish a


Federal District Court finds brand-name manufacturer’s alleged regulatory delay tactics a valid theory of attempted monopolization
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • January 9 2017

In a recent decision denying the Defendant’s motion to dismiss, Judge Mitchell Goldberg of the Eastern District of Pennsylvania allowed the


2016 antitrust developments: Foreshadowing 2017?
  • Porter Wright Morris & Arthur LLP
  • USA
  • January 4 2017

It’s that time of year again, when we reflect on what happened during the prior year and prepare for another one. Let’s take a moment to look at some


Nexium Case Extends Actavis Ruling
  • McDermott Will & Emery
  • USA
  • January 3 2017

Addressing a pay-for-delay and pharmaceutical-settlement antitrust jury trial for the first time since the 2012 Supreme Court of the United States


When Objecting Once Is Not Enough: Recognizing a Continuing Duty as the Charges and Verdict Form Evolve
  • Carlton Fields
  • USA
  • January 3 2017

On November 21, 2016, the First Circuit offered practitioners yet another reminder that, as the charges and verdict form evolve through colloquys


UK Competition Regulator Targets Big Pharma Over Excessive Pricing
  • Bryan Cave LLP
  • United Kingdom, USA
  • December 20 2016

Compare and contrast the current excessive pricing debates occurring in the US with those in the UK. In both markets, pharmaceutical firms are being